This is a synthetic peptide designed for use in combination with anti-CYP2A7 Antibody(ARP41799_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
CYP2A7
Reactivité: Humain, Souris, Rat
Hôte: Synthetic
BP
Indications d'application
Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Concentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Conseil sur la manipulation
Avoid repeated freeze-thaw cycles.
Stock
-20 °C
Stockage commentaire
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Antigène
CYP2A7
(Cytochrome P450, Family 2, Subfamily A, Polypeptide 7 (CYP2A7))
Synonymes
CPA7 Peptide, CPAD Peptide, CYP2A Peptide, CYPIIA7 Peptide, P450-IIA4 Peptide, cytochrome P450 family 2 subfamily A member 7 Peptide, CYP2A7 Peptide
Sujet
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum, its substrate has not yet been determined. This gene, which produces two transcript variants, is part of a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q.
Alias Symbols: CPA7, CPAD, CYP2A, CYPIIA7, P450-IIA4